跳至主要内容
临床试验/NCT01119716
NCT01119716已完成不适用

International Registry on Cardioversion of Atrial Fibrillation

Merck Sharp & Dohme LLC0 个研究点目标入组 4,658 人开始时间: 2010年5月25日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,658
主要终点
Clinical Type of Atrial Fibrillation at Baseline (Admission)

研究概览

简要总结

This study will create a prospective registry of consecutive patients with Atrial Fibrillation (Afib) considered for cardioversion treatment to document up-to-date practice of in-hospital treatment, with a focus on the characterization of type of Afib, as well as on treatments applied (drugs, devices, interventions and their combinations), and associated complications within 60 days after enrollment.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participant with documented atrial fibrillation (confirmed by electrocardiogram) in the hospital setting at the time of enrollment
  • Planned cardioversion (of atrial fibrillation)

排除标准

  • Already enrolled in this or any other clinical trial
  • Atrial flutter

结局指标

主要结局

Clinical Type of Atrial Fibrillation at Baseline (Admission)

时间窗: Baseline (time of admission)

Percentage of Participants Who Had a Successful Electrical or Pharmacological Cardioversion

时间窗: At time of treatment (up to 1 day from admission)

Pharmacological cardioversion was considered successful if sinus rhythm or atrial rhythm was obtained within 24 hours after its initiation. Electrical cardioversion was considered successful if sinus rhythm was obtained and maintained for at least 10 minutes after the last shock was administered.

Co-Morbidity in Participants Presenting With Atrial Fibrillation at Baseline (Admission)

时间窗: Baseline (time of admission)

Complications Experienced by Participants Who Underwent a Cardioversion for Treatment of Atrial Fibrillation

时间窗: up to 60 days from day of treatment (cardioversion)

Treatments Utilized for Participants for Atrial Fibrillation

时间窗: At time of Treatment (up to 1 day from admission)

Cardiovascular Disease History of Participants Presenting With Atrial Fibrillation at Baseline (Admission)

时间窗: Baseline (time of admission)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

International Registry on Cardioversion of Atrial... | 临床试验